Venrock Adviser, Llc Portfolio Stock Holdings

Venrock Adviser, Llc disclosed 33 stock positions valued at approximately $2.7 billion in its latest SEC 13F filing. The largest holdings include APOGEE THERAPEUTICS INC, ERASCA INC, and SPYRE THERAPEUTICS INC. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.

Report Period
March 31, 2026
No. of Stocks
33
Portfolio Value
$2.7B
Holdings by Sector
Venrock Adviser, Llc Portfolio Holdings in Q1 2026

21 holdings in the latest reporting period.

Page 1 of 1
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
APOGEE THERAPEUTICS INCAPGEHealthcare26.68%8,493,321--$714,882,829
ERASCA INCERASHealthcare9.89%16,382,812-1,474,271-8.26%$265,073,898
SPYRE THERAPEUTICS INCSYREHealthcare6.94%3,685,448--$185,893,997
KALVISTA PHARMACEUTICALS INCKALVHealthcare4.86%6,474,485-254,500-3.78%$130,331,383
DIANTHUS THERAPEUTICS INCDNTHHealthcare3.70%1,180,000+180,000+18.00%$99,025,600
OCULAR THERAPEUTIX INCOCULHealthcare3.27%10,346,926+3,031,379+41.44%$87,638,463
COGENT BIOSCIENCES INCCOGTHealthcare2.87%2,000,000--$76,980,000
VIRIDIAN THERAPEUTICS INCVRDNHealthcare2.83%3,882,709--$75,945,788
SAVARA INCSVRAHealthcare2.80%13,740,375--$75,022,448
ENLIVEN THERAPEUTICS INCELVNHealthcare2.53%1,726,331-1,500,000-46.49%$67,672,175
ORIC PHARMACEUTICALS INCORICHealthcare2.04%4,319,765-1,356,465-23.90%$54,731,423
CYTOMX THERAPEUTICS INCCTMXHealthcare1.75%9,982,124-5,579,376-35.85%$46,915,983
DYNE THERAPEUTICS INCDYNHealthcare1.47%2,173,913--$39,413,043
RELMADA THERAPEUTICS INCRLMDHealthcare1.26%4,843,380+4,843,380+100.00%$33,709,925
ENGENE HOLDINGS INCENGNHealthcare1.21%4,771,414--$32,493,329
TENAX THERAPEUTICS INCTENXHealthcare1.00%1,675,262+1,675,262+100.00%$26,787,439
CENTURY THERAPEUTICS INCIPSCHealthcare0.73%8,695,652+8,695,652+100.00%$19,652,174
CULLINAN THERAPEUTICS INCCGEMHealthcare0.73%1,379,965--$19,609,303
SURROZEN INCSRZNHealthcare0.69%632,931--$18,437,280
KORRO BIO INCKRROHealthcare0.43%1,009,500+1,009,500+100.00%$11,427,540
ALTO NEUROSCIENCE INCANROHealthcare0.42%500,000+500,000+100.00%$11,240,000